• DarioHealth expanded its partnership with Solera Health to add a broader hypertension program on Solera’s digital health network.
• The expansion extends eligibility from pre-hypertension through Stage 2 hypertension, more than doubling Dario’s addressable market within Solera.
• Eligible lives on Solera’s platform now exceed 500,000 for Dario, widening access beyond its core diabetes-focused population.
• Commercial terms shift toward a value-based model, with revenue more directly tied to engagement and clinical improvement over time.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DarioHealth Corp. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202605260800PR_NEWS_USPR_____LN66928) on May 26, 2026, and is solely responsible for the information contained therein.